IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients.
Milanez, Fernanda Manente
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. [electronic resource] - Arthritis research & therapy Feb 2016 - 52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1478-6362
10.1186/s13075-016-0949-6 doi
Adult
Antirheumatic Agents--therapeutic use
Cross-Sectional Studies
Dinoprostone--blood
Disease Progression
Female
Humans
Interleukin-17
Interleukin-23--blood
Male
Middle Aged
Spondylitis, Ankylosing--drug therapy
Th17 Cells--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. [electronic resource] - Arthritis research & therapy Feb 2016 - 52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1478-6362
10.1186/s13075-016-0949-6 doi
Adult
Antirheumatic Agents--therapeutic use
Cross-Sectional Studies
Dinoprostone--blood
Disease Progression
Female
Humans
Interleukin-17
Interleukin-23--blood
Male
Middle Aged
Spondylitis, Ankylosing--drug therapy
Th17 Cells--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors